77
Growth Score
pts
Heat Score
24 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
461750
Amborse cell therapy provides treatment to chronic degenerative disease patients using adipose-derived stem and regenerative cells.
Matt Feshbach: Founder & CEOPast Role: Okyanos Heart Institute, Founder & CEO
About the Company
Amborse cell therapy operates in compliance with House Bill 810, providing patients the right-to-try experimental stem cell treatments using adipose-derived stem and regenerative cells (ADRCs) with the goal of improving symptoms, function, and quality of life.
